Skip to main content

Table 1 Results of the additive, dominant and recessive TTT models. Polymorphisms with a BH-adjusted P-value < 0.1 are show

From: The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

rs ID P-value BH-adjusted P-value Reference Alternative Gene Symbol Hazard Ratio MAF
ADDTIVE MODEL
rs537453728 4.53E-08 5.39 E-3 CT C MAP3K4 7.08 0.01
rs361807 4.31E-07 0.01 T C PEX26 4.55 0.1
rs361946 4.31E-07 0.01 A G PEX26 4.55 0.1
rs1043278 4.31E-07 0.01 A G PEX26 4.55 0.1
rs7620924 5.08E-07 0.01 A G PPP4R2 0.24 0.49
rs5992169 9.55E-07 0.02 G A PEX26 4.45 0.11
rs9463 3.11E-06 0.05 G A TTLL12 3.18 0.42
rs55715863 3.84E-06 0.05 C A TXNRD2 5.24 0.01
rs3780333 3.84E-06 0.05 A G ZCCHC7 4.8 0.27
rs17016977 5.69E-06 0.07 A G MKI67IP 5.53 0.01
rs72842201 6.13E-06 0.07 A G MARCH.10 2.99 0.05
rs3172278 7.23E-06 0.07 T C PPP4R2 4.04 0.49
DOMINANT MODEL
rs3172278 2.40E-08 1.23E-03 T C PPP4R2 0.09 0.49
rs2247870 1.60E-07 4.10E-03 G A GPR98 0.4 0.47
rs9463 3.07E-07 5.26E-03 G A TTLL12 0.17 0.42
rs28656102 1.22E-06 0.02 T C PPP4R2 0.18 0.42
rs1045960 6.22E-06 0.05 C T PPP4R2 0.21 0.42
rs62039297 6.29E-06 0.05 G A SRL 0.2 0.26
rs9873229 9.72E-06 0.07 C T PPP4R2 0.22 0.44
RECESSIVE MODEL
rs7620924 8.07E-11 1.08E-05 A G PPP4R2 11.77 0.49
rs537453728 4.53E-08 3.04E-03 CT C MAP3K4 0.14 0.01
rs9310254 7.49E-07 0.03 T C PPP4R2 5.56 0.49